Who makes Diluted Humalog U-200 Insulin?

Diluted Humalog U-200 Insulin is developed by Stanford University.

What development phase is Diluted Humalog U-200 Insulin in?

Diluted Humalog U-200 Insulin is in Phase 1.

Last reviewed 2026-04-20 · How we verify

Diluted Humalog U-200 Insulin

Stanford University · Phase 1 active Small molecule Quality 0/100

At a glance

Generic name	Diluted Humalog U-200 Insulin
Sponsor	Stanford University
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Diluted Humalog U-200 Insulin CI brief — competitive landscape report
Diluted Humalog U-200 Insulin updates RSS · CI watch RSS
Stanford University portfolio CI